MEASUREMENT OF HEPARIN - METHOD BASED ON POTENTIATION OF ANTIFACTOR XA

被引：144
|
作者：
DENSON, KWE [1 ]
BONNAR, J [1 ]
机构：
[1] JOHN RADCLIFFE HOSP,OXFORD,ENGLAND
来源：
THROMBOSIS ET DIATHESIS HAEMORRHAGICA | 1973年 / 30卷 / 03期
关键词：
D O I：
10.1055/s-0038-1649125
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：471 / 479
页数：9
相关论文
共 50 条
  • [1] ANTIFACTOR XA ASSAY FOR EFFECTIVE MONITORING OF HEPARIN
    Paluri, Ravikumar
    Koya, Supriya
    Marques, Marisa
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2010, 25 : 492 - 492
  • [2] Weight-based heparin protocol using antifactor Xa monitoring
    Smith, Michael L.
    Wheeler, Kathryn E.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (05) : 371 - 374
  • [3] ANTITHROMBIN-III, ANTIFACTOR-XA AND HEPARIN
    BIGGS, R
    DENSON, KWE
    AKMAN, N
    BORRETT, R
    HADDEN, M
    BRITISH JOURNAL OF HAEMATOLOGY, 1970, 19 (03) : 283 - &
  • [4] Antifactor Xa Monitoring in Patients on IV Unfractionated Heparin
    John, Samuel M.
    Lisi, Dusty
    Greenfield, Nathan
    George, Mary Littleton
    US PHARMACIST, 2015, 40 (03) : HS26 - +
  • [5] PLATELET ANTIHEPARIN ACTIVITY - ASSAY BASED ON FACTOR-XA INACTIVATION BY HEPARIN AND ANTIFACTOR-XA
    WALSH, PN
    BIGGS, R
    GAGNATELLI, G
    BRITISH JOURNAL OF HAEMATOLOGY, 1974, 26 (03) : 405 - 419
  • [6] Perils of Antithrombotic Transitions: Effect of Oral Factor Xa Inhibitors on the Heparin Antifactor Xa Assay
    Ahuja, Tania
    Yang, Irene
    Huynh, Quy
    Papadopoulos, John
    Green, David
    THERAPEUTIC DRUG MONITORING, 2020, 42 (05) : 737 - 743
  • [7] Is measurement of antifactor XA necessary in the pregnant anticoagulated patient?
    Gyamfi, C
    Cohen, R
    Desancho, MT
    Gaddipati, S
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2003, 189 (06) : S147 - S147
  • [8] TREATMENT OF HEMOLYSIS WITH INTRAVENOUS UNFRACTIONATED HEPARIN USING AN ANTIFACTOR Xa-BASED MONITORING PROTOCOL
    Adatya, Sirtaz
    John, Ranjit
    Eckman, Peter M.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2015, 149 (05): : 1465 - 1466
  • [9] Achieving target antifactor Xa activity with a heparin protocol based on sex, age, height, and weight
    Rosborough, TK
    Shepherd, ME
    PHARMACOTHERAPY, 2004, 24 (06): : 713 - 719
  • [10] ANTITHROMBIN-III, HEPARIN COFACTOR AND ANTIFACTOR-XA IN A CLINICAL MATERIAL
    ODEGARD, OR
    TEIEN, AN
    THROMBOSIS RESEARCH, 1976, 8 (02) : 173 - 178
12345